JOHANNESBURG (Reuters) – The Coalition for Epidemic Preparedness (CEPI) will invest up to $50 million over 10 years to help Senegal’s Institut Pasteur produce vaccines for the South, it said on Thursday.
CEPI, a global initiative headquartered in Norway, is creating a network of vaccine manufacturers in developing countries to increase capacity and reserves for future outbreaks and pandemics.
“The facility will ensure that regional outbreaks are not neglected by deploying the latest technology for the greatest need,” said Amadou Alpha Sall, CEO of Institut Pasteur de Dakar, a non-profit organization in Senegal’s capital.
(Reporting by Nellie Peyton; editing by Alexander Winning)
